Skip to main content
Top
Published in: Neurological Sciences 5/2019

01-05-2019 | Myotonic Dystrophy | Original Article

Body composition analysis in patients with myotonic dystrophy types 1 and 2

Authors: Stojan Peric, Ivo Bozovic, Tanja Nisic, Marija Banovic, Milorad Vujnic, Tamara Svabic, Jovan Pesovic, Marija Brankovic, Ivana Basta, Milena Jankovic, Dusanka Savic-Pavicevic, Vidosava Rakocevic-Stojanovic

Published in: Neurological Sciences | Issue 5/2019

Login to get access

Abstract

Introduction

To date, there are only several reports on body composition in myotonic dystrophy type 1 (DM1) and there are no data for myotonic dystrophy type 2 (DM2). The aim was to analyze body composition of patients with DM1 and DM2, and its association with socio-demographic and clinical features of the diseases.

Methods

There were no statistical differences in sociodemographic features between 20 DM1 patients and 12 DM2 patients. Body composition was assessed by DEXA (dual-energy x-ray absorptiometry). A three-compartment model was used: bone mineral content (BMC), fat mass (FM), and lean tissue mass (LTM).

Results

Patients with DM1 and DM2 had similar total body mass (TBM), BMC, FM, and LTM. Patients with DM1 had higher trunk-limb fat index (TLFI) in comparison to DM2 patients which indicates visceral fat deposition in DM1 (1.16 ± 0.32 for DM1 vs. 0.87 ± 0.23 for DM2, p < 0.05). Right ribs bone mineral density was lower in DM2 group (0.68 ± 0.07 g/cm2 vs. 0.61 ± 0.09 g/cm2, p < 0.05). Higher percentage of FM in legs showed correlation with lower strength of the upper leg muscles in DM1 (ρ = − 0.47, p < 0.05). Higher muscle strength in DM2 patients was in correlation with higher bone mineral density (ρ = + 0.62, p < 0.05 for upper arm muscles, ρ = + 0.87, p < 0.01 for lower arm muscles, ρ = + 0.72, p < 0.05 for lower leg muscles).

Conclusion

DM1 patients had visceral obesity, and percentage of FM correlated with a degree of muscle weakness in upper legs. In DM2 patients, degree of muscle weakness was in correlation with higher FM index and lower bone mineral density.
Literature
1.
go back to reference Schara U, Schoser BG (2006) Myotonic dystrophies type 1 and 2: a summary on current aspects. Semin Pediatr Neurol 13:71–79CrossRefPubMed Schara U, Schoser BG (2006) Myotonic dystrophies type 1 and 2: a summary on current aspects. Semin Pediatr Neurol 13:71–79CrossRefPubMed
3.
go back to reference Harper PS, Monckton DG (2005) Myotonic dystrophy. In: Engel AG, Franzini-Amstrong C (eds) Myology: basic and clinical, 3rd edn. McGraw-Hill, New York, pp 1039–1076 Harper PS, Monckton DG (2005) Myotonic dystrophy. In: Engel AG, Franzini-Amstrong C (eds) Myology: basic and clinical, 3rd edn. McGraw-Hill, New York, pp 1039–1076
4.
go back to reference Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293(5531):864–867CrossRefPubMed Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293(5531):864–867CrossRefPubMed
6.
go back to reference Turner C, Hilton-Jones D (2010) The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry 81(4):358–367CrossRefPubMed Turner C, Hilton-Jones D (2010) The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry 81(4):358–367CrossRefPubMed
7.
go back to reference Aitkens SL, Kilmer DD, Wright NC, McCrory MA (2005) Metabolic syndrome in neuromuscular disease. Arch Phys Med Rehabil 86(5):1030–1036CrossRefPubMed Aitkens SL, Kilmer DD, Wright NC, McCrory MA (2005) Metabolic syndrome in neuromuscular disease. Arch Phys Med Rehabil 86(5):1030–1036CrossRefPubMed
8.
go back to reference Rakocevic-Stojanovic V, Peric S, Lavrnic D, Popovic S, Ille T, Stevic Z, Basta I, Apostolski S (2010) Leptin and the metabolic syndrome in patients with myotonic dystrophy type 1. Acta Neurol Scand 121(2):94–98CrossRefPubMed Rakocevic-Stojanovic V, Peric S, Lavrnic D, Popovic S, Ille T, Stevic Z, Basta I, Apostolski S (2010) Leptin and the metabolic syndrome in patients with myotonic dystrophy type 1. Acta Neurol Scand 121(2):94–98CrossRefPubMed
9.
go back to reference Pruna L, Chatelin J, Pascal-Vigneron V, Kaminsky P (2011) Regional body composition and functional impairment in patients with myotonic dystrophy. Muscle Nerve 44(4):503–508CrossRefPubMed Pruna L, Chatelin J, Pascal-Vigneron V, Kaminsky P (2011) Regional body composition and functional impairment in patients with myotonic dystrophy. Muscle Nerve 44(4):503–508CrossRefPubMed
10.
go back to reference Cruz Guzmán Odel R, Chávez García AL, Rodríguez-Cruz M (2012) Muscular dystrophies at different ages: metabolic and endocrine alterations. Int J Endocrinol 2012:485376PubMed Cruz Guzmán Odel R, Chávez García AL, Rodríguez-Cruz M (2012) Muscular dystrophies at different ages: metabolic and endocrine alterations. Int J Endocrinol 2012:485376PubMed
11.
go back to reference Perseghin G, Comola M, Scifo P, Benedini S, De Cobelli F, Lanzi R, Costantino F, Lattuada G, Battezzati A, Del Maschio A, Luzi L (2004) Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1. Am J Clin Nutr 80(2):357–364CrossRefPubMed Perseghin G, Comola M, Scifo P, Benedini S, De Cobelli F, Lanzi R, Costantino F, Lattuada G, Battezzati A, Del Maschio A, Luzi L (2004) Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1. Am J Clin Nutr 80(2):357–364CrossRefPubMed
12.
go back to reference Tieleman AA, Jenks KM, Kalkman JS, Borm G, van Engelen BG (2011) High disease impact of myotonic dystrophy type 2 on physical and mental functioning. J Neurol 258(10):1820–1826CrossRefPubMedPubMedCentral Tieleman AA, Jenks KM, Kalkman JS, Borm G, van Engelen BG (2011) High disease impact of myotonic dystrophy type 2 on physical and mental functioning. J Neurol 258(10):1820–1826CrossRefPubMedPubMedCentral
13.
go back to reference Savić Pavićević D, Miladinović J, Brkušanin M, Šviković S, Djurica S, Brajušković G, Romac S (2013) Molecular genetics and genetic testing in myotonic dystrophy type 1. Biomed Res Int 2013:391821CrossRef Savić Pavićević D, Miladinović J, Brkušanin M, Šviković S, Djurica S, Brajušković G, Romac S (2013) Molecular genetics and genetic testing in myotonic dystrophy type 1. Biomed Res Int 2013:391821CrossRef
14.
go back to reference Mathieu J, Boivin H, Meunier D, Gaudreault M, Bégin P (2001) Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 56(3):336–340CrossRefPubMed Mathieu J, Boivin H, Meunier D, Gaudreault M, Bégin P (2001) Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 56(3):336–340CrossRefPubMed
15.
go back to reference Kleyweg RP, van der Meché FG, Schmitz PI (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain–Barré syndrome. Muscle Nerve 14(11):1103–1109CrossRefPubMed Kleyweg RP, van der Meché FG, Schmitz PI (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain–Barré syndrome. Muscle Nerve 14(11):1103–1109CrossRefPubMed
16.
go back to reference Peric S, Maksimovic R, Banko B, Durdic M, Bjelica B, Bozovic I, Balcik Y, Pesovic J, Savic-Pavicevic D, Rakocevic-Stojanovic V (2017) Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies. J Neurol 264(9):1899–1908CrossRefPubMed Peric S, Maksimovic R, Banko B, Durdic M, Bjelica B, Bozovic I, Balcik Y, Pesovic J, Savic-Pavicevic D, Rakocevic-Stojanovic V (2017) Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies. J Neurol 264(9):1899–1908CrossRefPubMed
17.
go back to reference Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, Otten RF, Bhakta D, Nair GV, Marashdeh MM, Zipes DP, Pascuzzi RM (2008) Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 358(25):2688–2697CrossRefPubMed Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, Otten RF, Bhakta D, Nair GV, Marashdeh MM, Zipes DP, Pascuzzi RM (2008) Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 358(25):2688–2697CrossRefPubMed
18.
go back to reference Sedehizadeh S, David Brook J, Maddison P (2017) Body composition and clinical outcome measures in patients with myotonic dystrophy type 1. Neuromuscul Disord 27(3):286–289CrossRefPubMed Sedehizadeh S, David Brook J, Maddison P (2017) Body composition and clinical outcome measures in patients with myotonic dystrophy type 1. Neuromuscul Disord 27(3):286–289CrossRefPubMed
19.
go back to reference Renna LV, Bosè F, Iachettini S, Fossati B, Saraceno L, Milani V, Colombo R, Meola G, Cardani R (2017) Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle. PLoS One 12(9):e0184987CrossRefPubMedPubMedCentral Renna LV, Bosè F, Iachettini S, Fossati B, Saraceno L, Milani V, Colombo R, Meola G, Cardani R (2017) Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle. PLoS One 12(9):e0184987CrossRefPubMedPubMedCentral
20.
go back to reference Passeri E, Bugiardini E, Sansone V, Pizzocaro A, Fulceri C, Valaperta R, Borgato S, Costa E, Bandera F, Ambrosi B, Meola G, Persani L, Corbetta S (2015) Gonadal failure is associated with visceral adiposity in myotonic dystrophies. Eur J Clin Invest 45(7):702–710CrossRefPubMed Passeri E, Bugiardini E, Sansone V, Pizzocaro A, Fulceri C, Valaperta R, Borgato S, Costa E, Bandera F, Ambrosi B, Meola G, Persani L, Corbetta S (2015) Gonadal failure is associated with visceral adiposity in myotonic dystrophies. Eur J Clin Invest 45(7):702–710CrossRefPubMed
21.
go back to reference Heatwole C, Bode R, Johnson NE, Dekdebrun J, Dilek N, Eichinger K, Hilbert JE, Logigian E, Luebbe E, Martens W, Mcdermott MP, Pandya S, Puwanant A, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT 3rd (2016) The myotonic dystrophy health index: correlations with clinical tests and patient function. Muscle Nerve 53(2):183–190CrossRefPubMed Heatwole C, Bode R, Johnson NE, Dekdebrun J, Dilek N, Eichinger K, Hilbert JE, Logigian E, Luebbe E, Martens W, Mcdermott MP, Pandya S, Puwanant A, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT 3rd (2016) The myotonic dystrophy health index: correlations with clinical tests and patient function. Muscle Nerve 53(2):183–190CrossRefPubMed
22.
go back to reference Dozio E, Passeri E, Cardani R, Benedini S, Aresta C, Valaperta R, Corsi Romanelli M, Meola G, Sansone V, Corbetta S (2017) Circulating irisin is reduced in male patients with type 1 and type 2 myotonic dystrophies. Front Endocrinol (Lausanne) 14(8):320CrossRef Dozio E, Passeri E, Cardani R, Benedini S, Aresta C, Valaperta R, Corsi Romanelli M, Meola G, Sansone V, Corbetta S (2017) Circulating irisin is reduced in male patients with type 1 and type 2 myotonic dystrophies. Front Endocrinol (Lausanne) 14(8):320CrossRef
23.
go back to reference Seijger CG, Drost G, Posma JM, van Engelen BG, Heijdra YF (2016) Overweight is an independent risk factor for reduced lung volumes in myotonic dystrophy type 1. PLoS One 11(3):e0152344CrossRefPubMedPubMedCentral Seijger CG, Drost G, Posma JM, van Engelen BG, Heijdra YF (2016) Overweight is an independent risk factor for reduced lung volumes in myotonic dystrophy type 1. PLoS One 11(3):e0152344CrossRefPubMedPubMedCentral
24.
go back to reference Danckworth F, Karabul N, Posa A, Hanisch F (2014) Risk factors for osteoporosis, falls and fractures in hereditary myopathies and sporadic inclusion body myositis - a cross sectional survey. Mol Genet Metab Rep 1:85–97CrossRefPubMedPubMedCentral Danckworth F, Karabul N, Posa A, Hanisch F (2014) Risk factors for osteoporosis, falls and fractures in hereditary myopathies and sporadic inclusion body myositis - a cross sectional survey. Mol Genet Metab Rep 1:85–97CrossRefPubMedPubMedCentral
25.
go back to reference Passeri E, Bugiardini E, Sansone VA, Valaperta R, Costa E, Ambrosi B, Meola G, Corbetta S (2013) Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies. J Neurol Sci 331(1–2):132–135CrossRefPubMed Passeri E, Bugiardini E, Sansone VA, Valaperta R, Costa E, Ambrosi B, Meola G, Corbetta S (2013) Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies. J Neurol Sci 331(1–2):132–135CrossRefPubMed
26.
go back to reference Terracciano C, Rastelli E, Morello M, Celi M, Bucci E, Antonini G, Porzio O, Tarantino U, Zenobi R, Massa R (2013) Vitamin D deficiency in myotonic dystrophy type 1. J Neurol 260(9):2330–2334CrossRefPubMed Terracciano C, Rastelli E, Morello M, Celi M, Bucci E, Antonini G, Porzio O, Tarantino U, Zenobi R, Massa R (2013) Vitamin D deficiency in myotonic dystrophy type 1. J Neurol 260(9):2330–2334CrossRefPubMed
27.
go back to reference Dogan C, De Antonio M, Hamroun D, Varet H, Fabbro M, Rougier F, Amarof K, Arne Bes MC, Bedat-Millet AL, Behin A, Bellance R, Bouhour F, Boutte C, Boyer F, Campana-Salort E, Chapon F, Cintas P, Desnuelle C, Deschamps R, Drouin-Garraud V, Ferrer X, Gervais-Bernard H, Ghorab K, Laforet P, Magot A, Magy L, Menard D, Minot MC, Nadaj-Pakleza A, Pellieux S, Pereon Y, Preudhomme M, Pouget J, Sacconi S, Sole G, Stojkovich T, Tiffreau V, Urtizberea A, Vial C, Zagnoli F, Caranhac G, Bourlier C, Riviere G, Geille A, Gherardi RK, Eymard B, Puymirat J, Katsahian S, Bassez G (2016) Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a nationwide multiple databases cross-sectional observational study. PLoS One 11(2):e0148264CrossRefPubMedPubMedCentral Dogan C, De Antonio M, Hamroun D, Varet H, Fabbro M, Rougier F, Amarof K, Arne Bes MC, Bedat-Millet AL, Behin A, Bellance R, Bouhour F, Boutte C, Boyer F, Campana-Salort E, Chapon F, Cintas P, Desnuelle C, Deschamps R, Drouin-Garraud V, Ferrer X, Gervais-Bernard H, Ghorab K, Laforet P, Magot A, Magy L, Menard D, Minot MC, Nadaj-Pakleza A, Pellieux S, Pereon Y, Preudhomme M, Pouget J, Sacconi S, Sole G, Stojkovich T, Tiffreau V, Urtizberea A, Vial C, Zagnoli F, Caranhac G, Bourlier C, Riviere G, Geille A, Gherardi RK, Eymard B, Puymirat J, Katsahian S, Bassez G (2016) Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a nationwide multiple databases cross-sectional observational study. PLoS One 11(2):e0148264CrossRefPubMedPubMedCentral
28.
go back to reference Bozovic I, Peric S, Pesovic J, Bjelica B, Brkusanin M, Basta I, Bozic M, Sencanic I, Marjanovic A, Brankovic M, Savic-Pavicevic D, Rakocevic-Stojanovic V (2018) Myotonic dystrophy type 2 - data from the Serbian registry. J Neuromuscul Dis 5(4):461–469CrossRefPubMed Bozovic I, Peric S, Pesovic J, Bjelica B, Brkusanin M, Basta I, Bozic M, Sencanic I, Marjanovic A, Brankovic M, Savic-Pavicevic D, Rakocevic-Stojanovic V (2018) Myotonic dystrophy type 2 - data from the Serbian registry. J Neuromuscul Dis 5(4):461–469CrossRefPubMed
29.
go back to reference Rakocevic-Stojanovic V, Peric S, Basta I, Dobricic V, Ralic V, Kacar A, Peric M, Novakovic I (2015) Variability of multisystemic features in myotonic dystrophy type 1-lessons from Serbian registry. Neurol Res 37(11):939–944CrossRefPubMed Rakocevic-Stojanovic V, Peric S, Basta I, Dobricic V, Ralic V, Kacar A, Peric M, Novakovic I (2015) Variability of multisystemic features in myotonic dystrophy type 1-lessons from Serbian registry. Neurol Res 37(11):939–944CrossRefPubMed
Metadata
Title
Body composition analysis in patients with myotonic dystrophy types 1 and 2
Authors
Stojan Peric
Ivo Bozovic
Tanja Nisic
Marija Banovic
Milorad Vujnic
Tamara Svabic
Jovan Pesovic
Marija Brankovic
Ivana Basta
Milena Jankovic
Dusanka Savic-Pavicevic
Vidosava Rakocevic-Stojanovic
Publication date
01-05-2019
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 5/2019
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-03763-0

Other articles of this Issue 5/2019

Neurological Sciences 5/2019 Go to the issue